Press Releases 2011
-
Dec 15, 2011
:
SYGNIS Announces Key Results of its Phase II Trial of AX200 in Acute Ischemic Stroke
-
Nov 25, 2011
:
Shareholders support management proposals at SYGNIS Pharma’s AGM with overwhelming majority
-
Nov 14, 2011
:
SYGNIS announces six months results of fiscal year 2011/2012
-
Nov 03, 2011
:
SYGNIS announces last patient treated in its AXIS 2 efficacy Study
-
Sep 15, 2011
:
SYGNIS further strengthens its patent position for AX200 for the treatment of stroke
-
Aug 11, 2011
:
SYGNIS announces three months results of fiscal year 2011/2012
-
Aug 09, 2011
:
SYGNIS successfully completes patient recruitment for AXIS 2 Study
-
Jun 29, 2011
:
SYGNIS announces financial results for fiscal year 2010/2011
-
May 05, 2011
:
SYGNIS strengthens its KIBRA-Project: first Patents announced for Europe and the USA
-
Mar 22, 2011
:
SYGNIS enters final stage with its Phase II efficacy study of AX200 for the treatment of acute stroke
-
Feb 14, 2011
:
SYGNIS announces nine month results of fiscal year 2010/2011
-
Feb 09, 2011
:
SYGNIS strengthens patent position on AX200 for the treatment of neurodegenerative diseases